On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...